<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks — Live Feed</title><link>https://www.live-feeds.com/feed/ftc-states-ask-court-to-hold-pharma-bro-shkreli-in-contempt-for-trading-drug-stocks</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/ftc-states-ask-court-to-hold-pharma-bro-shkreli-in-contempt-for-trading-drug-stocks/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>FTC and Seven States Seek Contempt Ruling Against Martin Shkreli</title><link>https://www.live-feeds.com/feed/ftc-states-ask-court-to-hold-pharma-bro-shkreli-in-contempt-for-trading-drug-stocks</link><guid isPermaLink="false">https://www.live-feeds.com/feed/ftc-states-ask-court-to-hold-pharma-bro-shkreli-in-contempt-for-trading-drug-stocks#u130836</guid><pubDate>Sun, 18 Oct 2026 06:22:10 +0000</pubDate><description>The Federal Trade Commission and seven states have asked a federal judge to hold Martin Shkreli in contempt of court. Authorities allege Shkreli repeatedly and flagrantly violated a 2022 court order that banned him for life from the pharmaceutical industry. The current filing claims Shkreli violated these terms by trading drug stocks and livestreaming his activities. The 2022 order specifically prohibits Shkreli from making business decisions or holding ownership stakes within the pharmaceutical sector.Why it mattersShkreli received the lifetime ban after a trial determined he organized an ill</description></item>
</channel></rss>